Sindan Pharma also posted RON6.7 million profit, double as much as in 2018, and has more than 200 employees.
Teva group acquired the plant in Bucharest, previously held by Actavis (Irish-held Allergan’s generic drug division) in 2016, following an international deal that included the facility in Romania.
The revenue of the plant was flat in 2017 but doubled to RON64 million in 2018.
Sindan makes oncology drugs that reach 75 markets throughout the world.
Teva started selling its products via a local wholesaler in Romania 22 years ago. It opened its own subsidiary, Teva Pharmaceuticals SRL, in 2006.
(English version by Loredana Fratila-Cristescu)